VWF and thrombotic thrombocytopenic purpura: Nevertheless, a first step toward treating a patient with suspected TA-TMA features is to rule out TTP by documenting normal levels (>10%) of ADAMTS13 and normal von Willebrand Factor (vWF) multimers, since treatment of TTP differs significantly from TA-TMA.